{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:22:20Z","timestamp":1786980140893,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2010,4,28]],"date-time":"2010-04-28T00:00:00Z","timestamp":1272412800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1007\/s00417-010-1389-7","type":"journal-article","created":{"date-parts":[[2010,4,27]],"date-time":"2010-04-27T05:54:16Z","timestamp":1272347656000},"page":"1193-1198","source":"Crossref","is-referenced-by-count":19,"title":["Safety and feasibility of a novel intravitreal tamponade using a silicone oil\/acetyl-salicylic acid suspension for proliferative vitreoretinopathy: first results of the Austrian Clinical Multicenter Study"],"prefix":"10.1007","volume":"248","author":[{"given":"Martina Theresa","family":"Kralinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Stolba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Velikay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Egger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Binder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Wedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marie","family":"Parel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard Franz","family":"Kieselbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,4,28]]},"reference":[{"key":"1389_CR1","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/00006982-199801000-00010","volume":"18","author":"MN Asiyo-Vogel","year":"1998","unstructured":"Asiyo-Vogel MN, El-Hifnawi ES, Bopp S, Laqua H (1998) The vascular component of proliferative vitreoretinopathy membranes: an immunohistochemical and ultrastructural study. Retina 18:56\u201361","journal-title":"Retina"},{"key":"1389_CR2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4612-3910-9_1","volume-title":"Proliferative vitreoretinopathy","author":"C Claes","year":"1988","unstructured":"Claes C, Freeman HM, Tolentino FI (1988) PVR: an overview. In: Freeman HM, Tolentino FI (eds) Proliferative vitreoretinopathy. Springer, Berlin Heidelberg New York , pp 3\u201311"},{"key":"1389_CR3","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1136\/bjo.62.11.737","volume":"62","author":"R Machemer","year":"1978","unstructured":"Machemer R (1978) Pathogenesis and classification of massive periretinal proliferation. Br J Ophthalmol 62:737\u2013740","journal-title":"Br J Ophthalmol"},{"key":"1389_CR4","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archopht.1974.03900060459006","volume":"91","author":"GF Hilton","year":"1974","unstructured":"Hilton GF (1974) Subretinal pigment migration: effects of cryosurgical reattachment. Arch Ophthalmol 91:445","journal-title":"Arch Ophthalmol"},{"key":"1389_CR5","first-page":"286","volume":"114","author":"J Lean","year":"1996","unstructured":"Lean J, Azen SP, Lopez PF, Qian D, Lai MY, McCuen B (1996) The prognostic utility of the Silicone Study Classification System. Silicone Study Report 9. Silicone Study Group. Arch. Ophthalmol 114:286\u2013292","journal-title":"Ophthalmol"},{"key":"1389_CR6","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1001\/archopht.1979.01020010230008","volume":"97","author":"WF Rachal","year":"1979","unstructured":"Rachal WF, Burton TC (1979) Changing concepts of failure after retinal detachment surgery. Arch Ophthalmol 97:480\u2013483","journal-title":"Arch Ophthalmol"},{"key":"1389_CR7","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0002-9394(14)77967-X","volume":"99","author":"Silicone Study Group","year":"1985","unstructured":"Silicone Study Group (1985) Proliferative vitreoretinopathy. Am J Ophthalmology 99:593\u2013595","journal-title":"Am J Ophthalmology"},{"key":"1389_CR8","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0161-6420(89)32828-4","volume":"96","author":"ND Brourman","year":"1989","unstructured":"Brourman ND, Blumenkranz MS, Cox MS, Trese MT (1989) Silicone oil for the treatment of severe proliferative diabetic retinopathy. Ophthalmology 96:759\u2013764","journal-title":"Ophthalmology"},{"key":"1389_CR9","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00006982-199313040-00002","volume":"13","author":"BW McCuen 2nd","year":"1993","unstructured":"McCuen BW 2nd, Azen SP, Stern W, Lai MY, Lean JS, Linton KL, Ryan SJ (1993) Vitrectomy with silicone oil or perfluoropropane gas in eyes with severe proliferative vitreoretinopathy. Silicone Study Report 3. Retina 13:279\u2013284","journal-title":"Retina"},{"key":"1389_CR10","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1001\/archopht.1992.01080180042027","volume":"110","author":"Silicone Study Group","year":"1992","unstructured":"Silicone Study Group (1992) Vitrectomy with silicone oil or sulfur hexafluoride gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial. Silicone Study Report 1. Arch Ophthalmol 110:770\u2013779","journal-title":"Arch Ophthalmol"},{"key":"1389_CR11","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1001\/archopht.1992.01080180052028","volume":"110","author":"Silicone Study Group","year":"1992","unstructured":"Silicone Study Group (1992) Vitrectomy with silicone oil or perfluoropropane gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial. Silicone Study Report 2. Arch Ophthalmol 110:780\u2013790","journal-title":"Arch Ophthalmol"},{"key":"1389_CR12","first-page":"2131","volume-title":"Retina, vol 3","author":"J-M Parel","year":"1994","unstructured":"Parel J-M, Villain F (1994) Silicone oils: physicochemical properties. In: Ryan SJ (ed) Retina, vol 3, 2nd edn. Mosby, St. Louis, pp 2131\u20132149","edition":"2"},{"issue":"5","key":"1389_CR13","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/00006982-200110000-00015","volume":"21","author":"MT Kralinger","year":"2001","unstructured":"Kralinger MT, Kieselbach GF, Voigt M, Parel J-M (2001) Slow release of acetylsalicylic acid by intravitreal silicone oil. Retina 21(5):513\u2013520","journal-title":"Retina"},{"key":"1389_CR14","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s004170100255","volume":"239","author":"MT Kralinger","year":"2001","unstructured":"Kralinger MT, Hamasaki D, Kieselbach FG, Voigt M, Parel J-M (2001) Intravitreal acetylsalicylic acid in silicone oil: pharmacokinetics and evaluation of safety by ERG and histology. Graefe\u2019s Arch Clin Exp Ophtalmol 239:208\u2013216","journal-title":"Graefe\u2019s Arch Clin Exp Ophtalmol"},{"key":"1389_CR15","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.2042-7158.1988.tb05185.x","volume":"40","author":"P Valeri","year":"1988","unstructured":"Valeri P, Romanelli L, De Paolis L, Martinelli B (1988) Ocular distribution of aspirin and salicylate following systematic administration of aspirin to rabbits. J Pharm Pharmacol 40:823\u2013824","journal-title":"J Pharm Pharmacol"},{"key":"1389_CR16","first-page":"465","volume":"6","author":"P Valeri","year":"1989","unstructured":"Valeri P, Romanelli L, Martinelli B, Guglielmotti A, Catanese B (1989) Time-course of aspirin and salicylate in ocular tissues of rabbits. Lens Eye Toxic Res 6:465\u2013475","journal-title":"Lens Eye Toxic Res"},{"issue":"10","key":"1389_CR17","first-page":"3299","volume":"43","author":"M Voigt","year":"2002","unstructured":"Voigt M, Kralinger M, Kieselbach G, Chapon P, Anagnoste S, Hayden B, Parel J-M (2002) Ocular aspirin distribution: a comparison of intravenous, topical, and Coulomb-controlled iontophoresis administration. Invest Ophthalmol Vis Sci 43(10):3299\u20133306","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1389_CR18","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000069129","volume":"35","author":"MT Kralinger","year":"2003","unstructured":"Kralinger MT, Voigt M, Kieselbach GF, Hamasaki D, Hayden BC, Parel J-M (2003) Ocular delivery of acetylsalicylic acid by repetitive Coulomb-controlled iontophoresis. Ophthalmic Research 35:102\u2013110","journal-title":"Ophthalmic Research"},{"key":"1389_CR19","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0014-2999(94)90740-4","volume":"262","author":"C Kaehler","year":"1994","unstructured":"Kaehler C, Kieselbach G, Reinisch N, Troger J, G\u00f6ttinger W, Wiedermann CJ (1994) Fibroblast growth-promoting activity in proliferative vitreoretinopathy: antagonism by AS. Eur J Pharmacol 262:261\u2013269","journal-title":"Eur J Pharmacol"},{"key":"1389_CR20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00006982-198400410-00009","volume":"4","author":"IM Chan","year":"1984","unstructured":"Chan IM, Tolentino FI, Refojo MF, Fournier G, Albert DM (1984) Vitreous substitute: experimental studies and review. Retina 4:51\u201359","journal-title":"Retina"},{"key":"1389_CR21","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/00006982-198400440-00010","volume":"4","author":"K Miyamoto","year":"1984","unstructured":"Miyamoto K, Refojo MF, Tolentino FI, Fournier GA, Albert DM (1984) Perfluoroether liquid as a long term vitreous substitute: an experimental study. Retina 4:264\u2013268","journal-title":"Retina"},{"key":"1389_CR22","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00006982-199313030-00011","volume":"13","author":"MH Arroyo","year":"1993","unstructured":"Arroyo MH, Refojo MF, Araiz JJ, Tolentino FL, Cajita VN, Elner VM (1993) Silicone oil as a delivery vehicle for BCNU in rabbit proliferative vitreoretinopathy. Retina 13:245\u2013250","journal-title":"Retina"},{"key":"1389_CR23","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.3109\/02713688809033224","volume":"7","author":"H Chung","year":"1988","unstructured":"Chung H, Tolentino FI, Cajita VN, Ueno N, Refojo MF (1988) BCNU in silicone oil in proliferative vitreoretinopathy: solubility, stability (in vitro and in vivo), and antiproliferative (in vitro) studies. Curr Eye Res 7:1199\u20131206","journal-title":"Curr Eye Res"},{"key":"1389_CR24","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1076\/ceyr.16.10.1030.9022","volume":"16","author":"JM Larrosa","year":"1997","unstructured":"Larrosa JM, Veloso AA Jr, Leong FL, Refojo MF (1997) Antiproliferative effect of intravitreal alpha-tocopherol and alpha-tocopheryl-acid-succinate in a rabbit model of PVR. Eye Curr Res 16:1030\u20131035","journal-title":"Eye Curr Res"},{"key":"1389_CR25","unstructured":"Nakagawa M, Refojo MF, Marin JF, Doi M, Tolentino Fl (1995) Retinoic acid in silicone and silicone-fluorosilicone copolymer oils in a rabbit model of proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 36:2388\u20132395"},{"key":"1389_CR26","first-page":"522","volume":"34","author":"JJ Araiz","year":"1993","unstructured":"Araiz JJ, Refojo MF, Arroyo MH, Leong FL, Albert DM, Tolentino FL (1993) Antiproliferative effect of retinoic acid in intravitreous silicone oil in an animal model of proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 34:522\u2013530","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"1389_CR27","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF00154210","volume":"14","author":"M Weller","year":"1990","unstructured":"Weller M, Wiedemann P, Heimann K (1990) Proliferative vitreoretinopathy-is it anything more than wound healing at the wrong place? Int Ophthalmol 14(2):105\u2013117","journal-title":"Int Ophthalmol"},{"key":"1389_CR28","first-page":"164","volume":"39","author":"P Esser","year":"1998","unstructured":"Esser P, Tervooren D, Heimann K, Kociok N, Bartz-Schmidt KU, Walter P, Weller M (1998) Intravitreal daunomycin induces multidrug resistance in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 39:164\u2013170","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1389_CR29","doi-asserted-by":"crossref","unstructured":"Hegazy HM, Peyman GA, Liang C, Unal MH, Molinari LC, Kazi AA (1998\u20131999) Use of perfluorocarbon liquids, silicone oil, and 5-fluorouracil in the management of experimental PVR. Int Ophthalmol 22(4):239\u2013246","DOI":"10.1023\/A:1006336831730"},{"issue":"4","key":"1389_CR30","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0002-9394(98)00115-9","volume":"126","author":"P Wiedemann","year":"1998","unstructured":"Wiedemann P, Hilgers RD, Bauer P, Heimann K (1998) Adjunctive daunorubicin in the treatment of proliferative vitreoretinopathy: results of a multicenter clinical trial. Daunomycin Study Group. Am J Ophthalmol 126(4):550\u2013559","journal-title":"Am J Ophthalmol"},{"key":"1389_CR31","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3928\/1542-8877-20030701-05","volume":"34","author":"K Shinohara","year":"2003","unstructured":"Shinohara K, Tanaka M, Sakuma T, Kobayashi Y (2003) Efficacy of daunorubicin encapsulated in liposome for the treatment of proliferative vitreoretinopathy. Ophthalmic Surg Lasers Imaging 34:299\u2013305","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"1389_CR32","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0169-409X(01)00200-9","volume":"52","author":"R Herrero-Vanrell","year":"2001","unstructured":"Herrero-Vanrell R, Refojo MF (2001) Biodegradable microspheres for vitreoretinal drug delivery. Adv Drug Deliv Rev 52:5\u201316","journal-title":"Adv Drug Deliv Rev"},{"key":"1389_CR33","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0169-409X(01)00192-2","volume":"52","author":"T Yasukawa","year":"2001","unstructured":"Yasukawa T, Kimura H, Tabata Y, Ogura Y (2001) Biodegradable scleral plugs for vitreoretinal drug delivery. Adv Drug Deliv Rev 52:25\u201336","journal-title":"Adv Drug Deliv Rev"},{"issue":"5","key":"1389_CR34","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1046\/j.1442-9071.2003.00687.x","volume":"31","author":"B Vote","year":"2003","unstructured":"Vote B, Wheen L, Cluroe A, Teoh H, McGeorge A (2003) Further evidence for proinflammatory nature of perfluorohexyloctane in the eye. Clin Experiment Ophthalmol 31(5):408\u2013414","journal-title":"Clin Experiment Ophthalmol"},{"issue":"8","key":"1389_CR35","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s00417-006-0496-y","volume":"245","author":"D Sandner","year":"2007","unstructured":"Sandner D, Herbrig E, Engelmann K (2007) High-density silicone oil (Densiron) as a primary intraocular tamponade: 12-month follow up. Graefes Arch Clin Exp Ophthalmol 245(8):1097\u20131105","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"1389_CR36","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1167\/iovs.06-0941","volume":"48","author":"J Mackiewicz","year":"2007","unstructured":"Mackiewicz J, Muehling B, Hiebl W, Meinert H, Maaijwee K, Kociok N, L\u00fcke C, Zagorski Z, Kirchhof B, Joussen AM (2007) In vivo retinal tolerance of various heavy silicone oils. Invest Ophthalmol Vis Sci 48(4):1873\u20131883","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"1389_CR37","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.ophtha.2005.04.013","volume":"112","author":"D Tognetto","year":"2005","unstructured":"Tognetto D, Minutola D, Sanguinetti G, Ravalico G (2005) Anatomical and functional outcomes after heavy silicone oil tamponade in vitreoretinal surgery for complicated retinal detachment: a pilot study. Ophthalmology 112(9):1574","journal-title":"Ophthalmology"},{"key":"1389_CR38","unstructured":"Analgesics and antipyretics. In: McEvoy GE, Litvak K, Walsh O (eds) American Hospital Formulary Service Drug Information. Bethesda, MD: American Society of Hospital Pharmacists Inc., 1989;962\u2013966"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-010-1389-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-010-1389-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-010-1389-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T15:49:25Z","timestamp":1635263365000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-010-1389-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,28]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["1389"],"URL":"https:\/\/doi.org\/10.1007\/s00417-010-1389-7","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,28]]}}}